Additionally, a recent study suggested that EVI1 upregulated NRAS expression through epigenetic silencing of miR-124; thus, targeting miR-124 may have potential in regard to the treatment of AML with mutated NRAS [162]. This evidence concerns the gene RUNX1 and acute myeloid leukemia.